The following are the sources for the EDS Awareness brochure titled “EDS: Hiding in plain sight”:

Marco Castori, MD, PhD
Ehlers-Danlos Syndrome, Hypermobility Type: An Underdiagnosed Hereditary Connective Tissue Disorder with Mucocutaneous, Articular, and Systemic Manifestations
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512326/

Howard P Levy, MD, PhD
GeneReviews
Ehlers-Danlos Syndrome, Hypermobility Type
Synonyms: EDS Hypermobility Type, EDS Type III, Ehlers-Danlos Syndrome Type III
Initial Posting: October 22, 2004; Last Update: September 13, 2012.
http://www.ncbi.nlm.nih.gov/books/NBK1279/

Dr. Neilson’s Webinar (EDS Awareness “Educational Series”)
https://www.chronicpainpartners.com/eds-educational-series-webinar-august-6-2014/

Dr. Heidi Collins’ general session, “If You Can’t Connect the Issues, Think Connective Tissues”
Presented at EDNF’s Learning Conference in Houston, 2014
https://www.youtube.com/watch?v=H0jaF6Rnuv4

Dr. Clair Francomano’s presentation, “Ehlers-Danlos’ Affect on Multiple Body Systems”
Presented at the 2013 TCAPP Conference
https://www.chronicpainpartners.com/dr-francomano-video-ehlers-danlos-affect-on-multiple-body-systems/

Sources for prevalence statistics:

• Brad Tinkle was our Medical Advisor for this brochure. Dr. Tinkle recommended that we use 1 in 100.  He agreed to quotation of his professional estimate: “1-5% of the general population”.

• Dr. Francomano and Dr. Grahame have cited similar numbers in public– approximately 1 in 100.
  Also, Dr. Neilson cited a similar statistic in his presentation.

• Marco Castori states “a frequency of 0.2–0.6%, with the lowest value better fitting for men and the highest for females, appears more realistic in Europe and USA. However, no systematic study accurately investigating the real incidence of JHS/EDS-HT has been performed to date.”  (He is talking about JHM/EDS-Hypermobility Type)
  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512326/

• Dr. Rodney Grahame’s study extrapolated that 5% of EDS cases are not being recognized. (See slide 20)
  http://www.rheumatology.org.uk/includes/documents/cm_docs/2012/0/0940_hypermobility_overmedicalised_a_debate.pdf